Breakthrough in breast cancer testing and treatment

It's breast cancer awareness month, and 702 host Azania Mosaka chats to Prof Justus Apffelstaedt who has over 20 years experience in the field of breast health and the management of breast cancer.

She talks to him about the use of genetic testing to create custom breast cancer treatment plans.

In the late 1990s and early 2000s, improvements in molecular genetic technologies which later lead to the development of gene expression profiling tests.

These tests are able to provide specialists with an indication of the gene profile of an individual person's tumours, and from there, an indication of the cancer prognosis.

Previously we relied on light microscopy, which has been around for the last 400 hundred years and it's always intriguing to me that there hasn't been anything better around to advise us whether cancers are aggressive or not.

Prof Justus Apffelstaedt, breast cancer specialist

I don't think its right to judge the aggressiveness of a tumour by the way it looks like in its outbody appearance.

Prof Justus Apffelstaedt, breast cancer specialist

We have to see if the spread of tumors and the cancer mitosis, which ultimately kill patients are a biological phenomenon or not, explains Apffelstaedt.

Apffelstaedt says tumours that have the capability of moving through tissue to the blood vessels are far more aggressive than tumours without such properties.

Molecular genetic testing is able to reduce the number of individuals who undergo chemotherapy and also saves lives due to a more aggressive treatment regime being prescribed for individuals who at first diagnosis would be seen as low risk, he adds.

Prof Justus Apffelstaedt is an Associate Professor of Surgery at University of Stellenbosch and Head of the Tygerberg Breast Clinic

To hear the rest of the interview, listen below:


Recommended

by NEWSROOM AI

702 welcomes all comments that are constructive, contribute to discussions in a meaningful manner and take stories forward.

However, we will NOT condone the following:

  • Racism (including offensive comments based on ethnicity and nationality)
  • Sexism
  • Homophobia
  • Religious intolerance
  • Cyber bullying
  • Hate speech
  • Derogatory language
  • Comments inciting violence.

We ask that your comments remain relevant to the articles they appear on and do not include general banter or conversation as this dilutes the effectiveness of the comments section.

We strive to make the 702 community a safe and welcoming space for all.

702 reserves the right to: 1) remove any comments that do not follow the above guidelines; and, 2) ban users who repeatedly infringe the rules.

Should you find any comments upsetting or offensive you can also flag them and we will assess it against our guidelines.

702 is constantly reviewing its comments policy in order to create an environment conducive to constructive conversations.

Read More
How reliable is PSA (prostate cancer) test?

How reliable is PSA (prostate cancer) test?

Prostate-specific antigen (PSA) is a blood test used primarily to check for prostate cancer.

About 70% of breast cancer survivors suffer sexual dysfunction - Dr Eve

About 70% of breast cancer survivors suffer sexual dysfunction - Dr Eve

Clinical sexologist, Dr. Eve discusses how cancer hampers sexual relationships.

South African indigenous plant (Geelbos) could help in cancer treatment

South African indigenous plant (Geelbos) could help in cancer treatment

Although no human trials were done, the plant has proved effective to kill cancer cells in a laboratory setting.

More pharmaceutical companies may be implicated in price fixing -Cancer Alliance

More pharmaceutical companies may be implicated in price fixing -Cancer Alliance

Three major companies are being investigated for the suspected excessive pricing of life saving cancer medication in the country.

Three pharmaceutical companies probed for excessive pricing of cancer drugs

Three pharmaceutical companies probed for excessive pricing of cancer drugs

The three companies being investigated by the Competition Commission are generic Aspen Pharmacare, Roche and Pfizer.

What men need to know about checking for prostate cancer

What men need to know about checking for prostate cancer

Urologist and sexual health expert Dr Shingai Mutambirwa says it's vital for men above 40 to check their prostates annually.

Breast cancer risk factors explored

Breast cancer risk factors explored

Specialist Radiation Oncologist Dr. Sudeshen Naidoo talks about breast cancer, squashes myths and explores risk factors.

Popular articles
 In the market for a 2nd hand car? Here are some tips to buy it on a budget!

In the market for a 2nd hand car? Here are some tips to buy it on a budget!

In the car feature, our very own car guy Tumelo Maketekete shares some tips and tricks to buying a car on a R100 000 budget.

Vigilante mob attacks alleged criminals in Daveyton

Vigilante mob attacks alleged criminals in Daveyton

Tensions are rife in the East Joburg township as the community attacked and killed criminals.

[WATCH] Dad uses a drone to pull out son's tooth

[WATCH] Dad uses a drone to pull out son's tooth

Khabazela shares YouTube videos gone viral including a barmaid hitting a colleague who slapped her rear during a routine.

4 tips for safely investing right now when everything is so hectic

4 tips for safely investing right now when everything is so hectic

Bruce Whitfield asks Personal Financial Advisor Warren Ingram for advice on how investors can safely navigate this hectic time.

[Listen] Lottery responds to Tshepo's fraud claims

[Listen] Lottery responds to Tshepo's fraud claims

Philemon Letwaba says Tshepo's case relates to some of the issues that they are dealing with on a daily basis.